The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SV-BR-1-GM after progression on ADC in patients with metastatic breast cancer.
 
Chaitali Singh Nangia
Consulting or Advisory Role - Gilead Sciences; Gilead Sciences; Novartis; regeneron; Sanofi; Stemline Therapeutics
Speakers' Bureau - Merck; Novartis; Regeneron; Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Regeneron; Sanofi
 
Carmen Julia Calfa
No Relationships to Disclose
 
Blaise Bayer
Employment - Briacell
 
Mingjin Chang
No Relationships to Disclose
 
Tamar Aghajanian
Employment - Briacell
 
William Williams
Employment - Briacell
Leadership - Briacell
Stock and Other Ownership Interests - Briacell
 
Giuseppe Del Priore
Employment - Briacell
Leadership - Briacell
Stock and Other Ownership Interests - Briacell
Consulting or Advisory Role - UpToDate
 
Charles L. Wiseman
Employment - Briacell
Leadership - Briacell
Stock and Other Ownership Interests - Briacell
Consulting or Advisory Role - Briacell
 
Saranya Chumsri
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; bioTheranostics; bioTheranostics (Inst); Eisai; Immunomedics; Immunomedics; Immunomedics; Novartis; Novartis; Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Merck; Salix